Women are disproportionately affected by HIV, making up nearly half of new infections globally and in India. Stigma, gender ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...

To put this spike into perspective, the rural city of around 32,000 people has now recorded more HIV cases in two years than ...

Liberia's HIV cases have increased to approximately 36,000 people, up from 34,000 last year, according to new UNAIDS Spectrum 2025 data released Thursday by the National AIDS Commission (NAC). The ...

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

Details in the report further indicate that South Buganda has the highest HIV prevalence, followed by Acholi, Ankole, Lango, North Buganda and Kampala ...

Administration officials say South Africa has “significant means” to fund a promising new drug, lenacapavir, on its own.

As of 2024, over 40 million people in the world are diagnosed with human immunodeficiency virus (HIV)-a chronic, life-threatening infection that remains one of the leading global causes of death.

The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

Deniz Gökengin thinks colleagues view her as “a very serious, hardworking, meticulous, control-freak type of person”. But she ...